MetaCap

Evotec Statistics

NASDAQ: EVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.32-0.13 (-8.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Evotec by the numbers

Evotec has a market capitalization of $469.1 million based on 355.39M shares outstanding. With trailing EPS of $-0.59, Evotec is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.5% below its 50-day average and 44.3% below its 200-day average.

Average daily trading volume is 109.16K shares, or about $144,086 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

EVO valuation vs. peer median

EVO compared with the median of 8 peer companies
MetricEVOPeer medianDifference
Market cap$469.11M$461.00M+2%
Avg. volume109.16K308.58K-65%

Peer median across 8 companies: MNPR, RZLT, BLSM, GYRE, NGNE, ASMB, STTK, HELP.

Valuation

Price and trading

Previous close
1.45
Open
1.38
Day range
1.32 – 1.38
52-week range
1.32 – 3.87
52-week change
-55.56%
Beta
—
Volume
77.59K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
469.11M
Forward Pe
-6.95
Eps
-0.59
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.87
Week52 Low
1.32
Avg Volume
109.16K
Shares Outstanding
355.39M
Ma50
1.56
Ma200
2.37
Earnings Date
Nov 5, 2026
Pct From52w High
-65.89%
Pct From52w Low
0.00%

Related